M. Cazzola (Naples, Italy), L. Chovan (Bratislava, Slovakia)
Is there a role for standardised oxygen assessment for respiratory patients
K. Pye, G. Thompson, L. Davies, P. Calverley (Liverpool, United Kingdom)
|  |
Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment
M. Boorsma, R. Lutter, M. A. van de Pol, H. M. Jansen, R. E. Jonkers (Amsterdam, Netherlands)
| |
Improvement in HRQoL of COPD patients after 9 months‘ treatment with tiotropium bromide: use of a new scale for daily medical practice
A. B. Tonnel, T. Perez, J. M. Grosbois, M. L. Bravo, M. Brun (Lille, Reims, France)
| |
Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients
E. Yalniz, S. Tekgül, M. Gayaf, M. A. Ucar, N. Tasdogen, B. Komurcuoglu, E. Celikten (Izmir, Turkey)
| |
Effects of hypoxemia correction by acute O2 supply on endurance exercise testing in COPD patients
F. Durand, N. Heraud, A. Varray, C. Prefaut (Montpellier, Osseja, France)
| |
Methylprednisolone can improve isolated nocturnal hypoxemia in stable COPD patients
B. Sposato, G. Migliorini, S. Mariotta, A. Ricci, E. Canneti, L. Mancini, A. Grieco, P. Bruno, R. Martinelli, C. Franco (Grosseto, Rome, Italy)
| |
Straight assess in vivo of the influence inhalations NaCl for mucociliary clearance patients COPD and non-obstructive bronchitis
K. Viacheslav, G. Evgeniy, A. Anatoliy, B. Maryna, P. Tatyana (St. Petersburg, Russian Federation)
| |
Adequacy and observance of long-term oxygen therapy in severe COPD patients documented by 24-hour oxymetric follow-up
D. Alfandary (Corbeil Essonnes, France)
| |
Effects of iptkalim hydrochloride on endothelin-1-induced pulmonary hypertension in rats
H. Wang, X. Zhang, W. Xie (Nanjing, China)
| |
Evaluation of respiratory muscles‘ function in COPD patients treated with tiotropium
O. V. Myronenko (Dniepropetrovsk, Ukraine)
| |
One year follow up in COPD with oxygen: mortality and hospitalization
Z. G. Gabriel, E. Sanchez, J. Oruesagasti, J. Benavente, E. Maiz, G. Ceceaga, J. Vivanco, A. Cabarcos (San Sebastian, Spain)
| |
Management of COPD by pulmonologists in Poland
P. Kuca, R. Plywaczewski, P. Ptasznik, J. Zielinski (Warsaw, Poland)
| |
Combination therapy with salmeterol and fluticasone propionate (SFC) is more effective than salmeterol (SAL) alone in reducing exacerbations of COPD
P. Kardos, M. Wencker, T. Glaab, C. Vogelmeier (Frankfurt, Marburg, Munich, Germany)
| |
Managing chronic obstructive pulmonary disease (COPD) in real life: the role of adding tiotropium bromide in relation to quality of life and costs
I. N. Fiks, T. Antunes, J. B. Morato (Sao Paulo, Brazil)
| |
A comparison of salmeterol xinafoate (SX) plus beclomethasone dipropionate (BDP) and theophylline (Theo) plus BDP in the treatment of moderate chronic obstructive pulmonary disease (COPD)
M. D. Filipovic, S. S. Cekic, D. A. Stojanov, D. T. Ristic (Nis, Serbia And Montenegro)
| |
Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD)
K. J. Karwat, M. Szpotanska, Z. Szulc, R. Chazan (Warsaw, Poland)
| |
The effect of long-term treatment with erdosteine on moderate or severe COPD patients
M. Moretti, R. Assereto (Modena, Milan, Italy)
| |
Dietary and nutrient intake profile in Japanese COPD patients
T. Kutsuzawa, Y. Anzai, S. Shioya (Isehara, Japan)
| |
Does short-term treatment intensification influence long-term treatment effects on health status in COPD?
P. W. Jones, E. Ståhl (London, United Kingdom; Lund, Sweden)
| |
Inhibition of reactive nitrogen species production in COPD airways: comparison between steroid and theophylline
T. Hirano, M. Nakanishi, M. Gohda, T. Yamagata, K. Fukui, K. Ueshima, K. Akamatsu, Y. Yamagata, K. Matsunaga, Y. Minakata, M. Ichinose (Wakayama, Japan)
| |